If we are to exploit the full potential of IgA as an immunomodulatory immunoglobulin in mucosal diseases such as asthma, we need to understand better how IgA synthesis is regulated and how we can promote the synthesis of IgA through the use of adjuvants. This evidence concerns the gene CD79A and asthma.